Brachytherapy involves placing radioactive material close to cancerous tissues. It allows for higher and more precise radiation doses to be delivered to cancerous areas while minimizing radiation exposure to surrounding healthy tissues. Brachytherapy is often used to treat cancers of the breast, prostate, cervix, head and neck, lung, and skin.
The global Brachytherapy Market is estimated to be valued at US$ 972.21 Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
It improves access to brachytherapy in community settings and allows treatment of a wider range of tumor sites. Development of miniature radioactive sources enables minimally invasive delivery methods like high dose rate brachytherapy using thin catheters, intraoperative radiation therapy and superficial brachytherapy without surgery. Technological advancements in imaging, applicator design and treatment planning have also enhanced precision and efficacy of brachytherapy.
Segment Analysis
The Global Brachytherapy Market Size is segmented into technology, application, and end user. Based on technology, the brachytherapy market is segmented into high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy, and pulse dose rate (PDR) brachytherapy. The HDR brachytherapy segment dominated the market in 2022 owing to its advantages such as shorter treatment time and higher radiation doses which can be delivered in fractions.
Key Takeaways
The global brachytherapy market is expected to witness high growth, exhibiting CAGR of 7.1% over the forecast period, due to increasing incidence of cancer worldwide.
Regional analysis: North America dominated the global brachytherapy market in 2022 and is expected to continue its dominance during the forecast period. This is attributed to the rise in cancer incidence and adoption of advanced treatment procedures in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to expansion of healthcare infrastructure and rising medical tourism in the region.
Key players analysis: Key players operating in the brachytherapy market are Varian Medical Systems, Elekta AB, Becton, Dickinson and Company, IsoRay, Inc., Eckert & Ziegler BEBIG, and iCAD. Varian Medical Systems and Elekta AB dominated the global market share in 2022 owing to their broader product portfolio and robust geographical presence across the globe.
For More Insights, Read- https://www.newsstatix.com/brachytherapy-market-size-share-analysis-2023-2030/
Comments
0 comment